Suppr超能文献

桥本甲状腺炎和原发性甲状腺淋巴瘤中p53和Bcl-2蛋白的免疫组织化学检测

Immunohistochemical detection of p53 and Bcl-2 proteins in Hashimoto's thyroiditis and primary thyroid lymphomas.

作者信息

Chetty R, O'Leary J J, Biddolph S C, Gatter K C

机构信息

University Department of Cellular Science, University of Oxford.

出版信息

J Clin Pathol. 1995 Mar;48(3):239-41. doi: 10.1136/jcp.48.3.239.

Abstract

AIMS

To investigate whether immunohistochemical staining using p53 and/or bcl-2 distinguishes between florid Hashimoto's thyroiditis and low grade mucosa associated lymphoid tissue (MALT) lymphoma of the thyroid.

METHODS

Ten cases of Hashimoto's thyroiditis and eight of primary thyroid lymphoma were stained with monoclonal antibodies directed against p53 and bcl-2.

RESULTS

In Hashimoto's thyroiditis most small lymphoid cells in mantle zones, within the thyroid parenchyma and in lymphoepithelial lesions expressed bcl-2 protein. Very occasional centroblasts in reactive germinal centres were positive for p53, but all other lymphoid cells from cases of Hashimoto's disease were negative for p53. In diffuse, low grade lymphomas bcl-2 protein was uniformly expressed by most tumour cells. However, low grade lymphomas with a follicular pattern did not express bcl-2. The diffuse, low grade lymphomas were negative for p53, while occasional larger cells in the follicular subtype were positive. Both high grade lymphomas were bcl-2 negative but strongly p53 positive.

CONCLUSIONS

This study indicates that there is an inverse correlation between p53 and bcl-2 immunostaining in thyroid lymphomas (low grade lymphomas: bcl-2 positive, p53 negative; high grade lymphomas: bcl-2 negative, p53 positive). Furthermore, immunohistochemical staining for bcl-2 and p53 proteins does not distinguish florid Hashimoto's thyroiditis from diffuse, low grade thyroid lymphoma.

摘要

目的

研究使用p53和/或bcl-2进行免疫组化染色能否区分弥漫性桥本甲状腺炎和甲状腺低度黏膜相关淋巴组织(MALT)淋巴瘤。

方法

用针对p53和bcl-2的单克隆抗体对10例桥本甲状腺炎和8例原发性甲状腺淋巴瘤进行染色。

结果

在桥本甲状腺炎中,甲状腺实质内套区以及淋巴上皮病变中的大多数小淋巴细胞表达bcl-2蛋白。反应性生发中心偶尔出现的中心母细胞p53呈阳性,但桥本氏病病例中的所有其他淋巴细胞p53呈阴性。在弥漫性低度淋巴瘤中,大多数肿瘤细胞均一致表达bcl-2蛋白。然而,具有滤泡型的低度淋巴瘤不表达bcl-2。弥漫性低度淋巴瘤p53呈阴性,而滤泡亚型中偶尔出现的较大细胞呈阳性。两种高度淋巴瘤bcl-2均为阴性,但p53强阳性。

结论

本研究表明,甲状腺淋巴瘤中p53和bcl-2免疫染色呈负相关(低度淋巴瘤:bcl-2阳性,p53阴性;高度淋巴瘤:bcl-2阴性,p53阳性)。此外,bcl-2和p53蛋白的免疫组化染色不能区分弥漫性桥本甲状腺炎和弥漫性低度甲状腺淋巴瘤。

相似文献

9
Clinicopathologic Characteristics and A20 Mutation in Primary Thyroid Lymphoma.原发性甲状腺淋巴瘤的临床病理特征及 A20 突变。
J Nippon Med Sch. 2022 Jun 28;89(3):301-308. doi: 10.1272/jnms.JNMS.2022_89-305. Epub 2021 Nov 26.
10
Association of Hashimoto's thyroiditis and thyroid cancer.桥本甲状腺炎与甲状腺癌的关联。
Curr Opin Oncol. 2015 Jan;27(1):21-5. doi: 10.1097/CCO.0000000000000150.

本文引用的文献

3
Apoptosis. Death gets a brake.细胞凋亡。死亡得到了抑制。
Nature. 1994 May 26;369(6478):272-3. doi: 10.1038/369272a0.
4
Heterogeneity of bcl-2 expression in MALT lymphoma.黏膜相关淋巴组织淋巴瘤中bcl-2表达的异质性。
Histopathology. 1995 Jan;26(1):75-8. doi: 10.1111/j.1365-2559.1995.tb00624.x.
7
Bcl-2 expression in lymphomas.淋巴瘤中的Bcl-2表达。
Lancet. 1991 Jan 19;337(8734):175-6. doi: 10.1016/0140-6736(91)90838-g.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验